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Abstract 
Two general pathological processes contribute to multiple sclerosis (MS): acute inflammation and 
degeneration. While magnetic resonance imaging (MRI) is highly sensitive in detecting abnormalities 
related to acute inflammation both clinically and in animal models of experimental autoimmune 
encephalomyelitis (EAE), the correlation of these readouts with acute and future disabilities has been 
found rather weak. This illustrates the need for imaging techniques addressing neurodegenerative 
processes associated with MS. 
In the present work we evaluated the sensitivity of different MRI techniques (T2 mapping, 
macrophage tracking based on labeling cells in vivo by ultrasmall particles of iron oxide (USPIO), 
diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI)) to detect histopathological 
changes in a novel animal model making use of intrinsic, temporally and spatially controlled 
triggering of oligodendrocyte cell death. This mouse model allows studying the MRI signature 
associated to neurodegenerative processes of MS in the absence of adaptive inflammatory components 
that appear to be foremost in the EAE models. Our results revealed pronounced T2 hyperintensities in 
brain stem and cerebellar structures, which we attribute to structural alteration of white matter by 
pronounced vacuolation. Brain areas were found devoid of significant macrophage infiltration in line 
with the absence of a peripheral inflammatory response. The significant decrease in diffusion 
anisotropy derived from DTI measures in these structures is mainly caused by a pronounced decrease 
in diffusivity parallel to the fiber indicative of axonal damage. Triggering of oligodendrocyte ablation 
did not translate into a significant increase in radial diffusivity. Only minor decreases in MT ratio have 
been observed, which is attributed to inefficient removal of myelin debris. 
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1. Introduction 
MS is commonly thought to involve two general pathological processes: acute inflammatory 
demyelination and axonal degeneration, though the relationship between these aspects is not fully 
investigated. The complex inflammatory cascade of lesion development includes T-cell and 
macrophage recruitment, BBB breakdown, demyelination, axonal damage, remyelination and gliosis 
(Prineas, 1984; Lassmann, 2005; Ludwin, 2006; Frohman et al., 2006). It has become clear that 
measures of acute inflammation are poor predictors of long-term disability. 
Magnetic resonance imaging (MRI) is considered one of the most sensitive techniques for diagnosis of 
the disease (Filippi et al., 2009; Bakshi et al., 2008; Leist and Marks, 2010). Due to their sensitivity to 
detect early pathological events and hence their potential prognostic value, MRI readouts such as 
gadolinium-enhanced MRI assessing blood-brain barrier leakage and transverse relaxation time (T2)-
weighted MRI assessing edema formation in conjunction with inflammatory processes have become 
essential components of the MS diagnosis process (Leist and Marks, 2010 and refs therein). 
Nevertheless, MRI suffers from several limitations with regard to MS diagnosis. In MS, lesions 
occurring include acute lesions as a result of an immune response mediated by monocytes and 
leukocytes, lesions characterized by oligodendrogliopathy or apoptosis, and remyelinated shadow 
plaques (Lassmann et al., 2001; Barnett and Prineas, 2004, Patrikios et al., 2006). Due to this 
heterogeneity and the complex interplay between inflammatory and degenerative processes, the 
histopathological correlates of MRI signal alterations are still poorly defined. This is reflected in the 
so-called ‘clinico-radiological paradox’ in MS (Barkhof et al., 2002), which refers to discrepancies 
between the disease burden as visualized by MRI and the extent of disability of patients. In order to 
improve the correlation between radiological disease markers and clinical status, a stronger 
weighting of neurodegenerative rather than primary inflammatory readouts has been suggested. 
MRI magnetization transfer ratio (MTR), which measures the exchange between bulk water and water 
bound to macromolecules, is considered a measure of the macromolecular structure (Wolff et al., 
1989) and myelin water fraction (Whittall et al., 1997), both potential measures of the degree of the 
myelination and the integrity of the myelin sheath. Diffusion tensor imaging (DTI) assessing 
directional diffusivity (Basser et al., 1994) might serve as an indicator of axonal integrity. Both MTR 
and DTI are linked to the neurodegenerative component of the disease (for review see Bakshi et al., 
2008; Filippi et al., 2009) and complement the established MRI readouts of inflammation. 
Animal models play a central role in the validation of clinical readouts as they allow direct correlation 
of radiological and histopathological findings. Not surprisingly, the various MRI methods have been 
applied to characterize animal models of MS such as rat and mouse models of experimental 
autoimmune encephalomyelitis (EAE). These models display disseminated and variable focal lesions 
at brain or spinal cord level (for review see Lassmann, 2008), which are difficult to interpret when 
using conventional T1– and T2-weighted MRI techniques sensitive for inflammatory processes only 
(Nessler et al., 2007; Serres et al., 2009). Therefore, in parallel to the clinical situation both DTI and 
MTR measures are currently being investigated as measures of demyelination, axonal damage or 
myelin integrity in EAE (Budde et al., 2008; Budde et al., 2009; DeBoy et al., 2007; Serres et al., 
2009; Rausch et al., 2003; Rausch et al., 2009) and CNS demyelination and remyelination in a mouse 
model of cuprizone-mediated demyelination (Sun et al., 2006; Zaaraoui et al., 2008). Furthermore, the 
use of ultra-small particles of iron oxide (USPIOs) to visualize macrophage infiltration has been 
proposed as refined marker for inflammatory events in MS and animal models thereof (Dousset et al., 
1999a; Rausch et al., 2003; Floris et al., 2004; Berger et al., 2006; Brochet et al., 2006; Ladewig et al., 
2009). 
Here we describe the MRI characterization of a novel mouse model of oligodendrogliopathy (Pohl et 
al., 2011) that has been generated using transgene mediated, intrinsic, temporally and spatially 
controlled triggering of oligodendrocyte cell death. This ablation of oligodendrocytes was achieved by 
selective inducible expression of diphtheria toxin fragment A (DT-A) in proteolipid protein (PLP)-
positive myelinating glia. The resulting pathology is characterized by a well-defined time course of 
myelin damage, which in turn resulted in a widespread status spongiosus of the myelin and axonal 
damage without involvement of adaptive immune cells. As the mouse model essentially lacks an 
inflammatory component, it should help identifying histopathological correlates accounting for MRI 
signal alteration associated to demyelination. Our objective was therefore to evaluate the sensitivity of 
various MRI readouts in 
characterizing the pathology. Assessment of clinical signs with a defined scoring procedure over the 
time course of disease development showed first incidence around 2 weeks after a 5-day consecutive 
treatment with tamoxifen to induce DT-A expression. We quantitatively assessed T2-values, changes 
in T2 as a consequence of CNS infiltration of USPIO carrying macrophages as indicator of an adaptive 
immune response, anisotropic water diffusion properties as marker of axonal integrity, and MTR as 
marker of myelin content in diseased mice prior to the occurrence of clinical impairments and at end 
stage of pathology. 
 
 
 
 
2. Methods 
2.1 Animals 
The transgenic mouse model was generated by crossing a mouse line expressing a tamoxifen inducible 
cyclic recombinase (Cre) under the PLP promoter active in oligodendrocytes (Leone et. al., 2003) with 
mice expressing DT-A after Cre-mediated recombination (Brockschnieder et al., 2004) allowing 
spatially and temporally controlled cell ablation (Pohl et al., 2011). Induction of DT-A expression was 
achieved by intraperitoneal (i.p.) injection of 2 mg TAM dissolved in a sunflower oil / ethanol mixture 
(10:1), for 5 consecutive days (start at day 1). For validation of MRI readouts male and female animals 
of 19-22 g body weight have been used. Animals were housed under a normal light/dark cycle (12:12 
h) with standard rodent chow and tap water ad libitum. 
 
2.2 Scoring 
Mice were monitored regularly and their impairment scored with a specially developed clinical scoring 
based on appearance of clinical signs modeled to reflect scorings used in EAE (Matthaei et al., 1989) 
in severity of occurrence: Score 0 = no observable clinical signs; score 1 = tremor and ataxia, 
broadened gait and reduced grip strength; score 2 = severe hind limb weakness plus pronounced ataxia 
and tremor; score 3 = animals temporarily fail to maintain upright position and both front and hind 
limbs showed severe weakness. Transition states were scored with half steps.  
 
2.3 Animal preparation for MRI acquisition 
Mice were anesthetized using 1.8 % isoflurane in an oxygen/air (20/80 %) mixture applied via a face-
mask with integrated tooth-bar and placed on water-heated cradle. Body temperature was monitored 
using a rectal probe coupled to a fluoroptic module (QUASYS AG, Cham, Switzerland) and kept 
constant at 37±0.5°C. Ear bars secured reproducible positioning and reduced motion artifacts. After 
completion of MRI studies all animals were sacrificed by transcardial perfusion fixation and brain was 
removed for histological analysis. All experiments were carried out in strict adherence to the Swiss 
Law for Animal Protection, approved by the veterinary office of the canton of Zurich, Switzerland. 
 
2.4 MRI 
MRI experiments were carried out with a Pharmascan 47/16 system (Bruker BioSpin MRI, Ettlingen, 
Germany) using a birdcage transmit-receive coil for quantitative T2 and MTR measurements and a 
cryogenic transmit-receive radiofrequency (RF) surface coil (Ratering et al., 2008) for DTI studies. 
Quantitative T2 values were obtained using a multi spin echo (SE) sequence with the parameters: 
field-of-view (FOV) = 19x19 mm2; matrix dimension (MD) = 132x132; spatial resolution = 144x144 
μm2; repetition time (TR) = 2000 ms; echo spacing (TE) = 10 ms; number of echoes: 14; number of 
averages (NA) = 6 and slice thickness (SLTH) = 0.8 mm. Diffusion-tensor Imaging: For DTI a multi-
slice spin echo-echo planar imaging (EPI) sequence was used with: number of slices (NSL) = 15; 
SLTH = 0.5 mm; interslice gap = 0.25 mm; FOV = 20x15 mm2; MD = 133x100; TE = 28.3 ms, TR = 
3000 ms; b-values = 1000 s/mm2 with 30 diffusion encoding directions. High resolution anatomical 
images were acquired using a standard spin echo rapid acquisition with relaxation enhancement (SE-
RARE) sequence (Hennig et al., 1986) with FOV = 20x18.4 mm2; MD = 256x256; in plane resolution 
of 78x72 μm2; TE = 12 ms; TR = 3500 ms; effective echo time (TEeff) = 36 ms; RARE factor = 8; 
NA = 7; SLTH = 0.800 mm; NSL = 9. MTI was performed using a 3D-gradient echo (GE) sequence 
with FOV = 15x15x12 mm3; MD: 60x60x48; isotropic voxel dimension of 250 μm3; TE = 2 ms; TR = 
30.0 ms; flip angle: 30°. A Gaussian pulse with pulse length of 1 ms, a B1 amplitude of 80 μT and an 
offset frequency of 5 kHz was used for saturation of the bound water fraction. The reference sequence 
was obtained using the same parameters without application of the saturation pulse. 
 
2.5 Study design: 
T2 maps have been recorded from twelve mice, eight of which received i.p. injection of TAM (i.p. 2 
mg; +TAM) while four littermates were used as control (no TAM injection: -TAM). In order to 
investigate potential alterations in macromolecular structure this group was further split, with half of 
the animals subjected to MTR. T2 and MTR maps were recorded at day 2 and 9 (baseline) as well as 
on day 37 and 41 (end stage) following TAM injection. The second half of the group was used to test 
for potential infiltration of macrophages by comparing T2 maps recorded prior and 24 h following 
intravenous (i.v.) USPIO administration (Sinerem®, Laboratoires Guerbet, Roissy, France) at a dose 
of 340 mol Fe/kg (injection volume: 2 ml/kg). USPIOs were administered immediately after the first 
T2 measurement (pre-USPIO). Post-USPIO T2 values were recorded at day 3, 10 and 38 following 
TAM. The elimination half-life of the USPIO used is approximately 5 h (Dousset et al., 1999b) and 
the time, during which USPIO-labeled macrophages remain visible in MR images, is of the order of 2–
3 days 
post-injection (Rausch et al., 2001). With an interval of 7 days between injections, the MR signal of 
subsequent measurements was not or only minimally affected by USPIOs administered during the 
previous imaging session. For the acquisition of DTI maps four treated (+TAM) and two littermate 
control mice (–TAM) were used. DTI experiments were carried out at day 3, 8 and 11 (baseline) and at 
day 35 and 39 (end stage) after start of TAM injections.  
 
2.6 Image analysis 
T2 and MTR maps were calculated using Biomap (M. Rausch, Novartis, Switzerland) with T2 derived 
from single-exponential fitting and MTR calculated as MTR(%) = (MS/M0)×100, with M0 and Ms 
representing the signal magnitude in the absence of a saturation pulse (control experiment) and the 
steady-state signal magnitude during MT saturation, respectively. Calculations of the invariant DTI-
based parametric maps, performed on a voxel-by-voxel basis, were done using an in-house software 
routine written in IDL (RSI, Boulder, USA). Diffusion-weighted images were processed to generate 
the six independent elements of the diffusion tensor D. A real eigenvalue decomposition of the 
symmetric tensor D yielded the orthonormal eigenvectors ei (i=1,2,3) and the diagonal matrix 
comprising the eigenvalues (1, 2 and 3). Quantitative invariant indices, such as axial diffusivity 
(λ║=1), radial diffusivity (λ┴=(2+3)/2) and fractional anisotropy (FA) were calculated according 
to Le Bihan et al (Le Bihan et al., 2001). FA is a measure of anisotropy of the water diffusion within a 
given voxel and by definition ranges between 0 (isotropic) and 1 (maximally anisotropic). Color-coded 
FA 
maps were generated using ParaVision® Jive. 
 2.7 Co-registration and Statistical analysis 
All calculated parasagittal T2 maps from the same individual were co-registered manually using affine 
transformation and T2 values for baseline (average of values of day 2 and 9) and end stage (average of 
values of day 37 and 41) for the defined ROIs (fx, frontal cortex; ob, olfactory bulb; cb, cerebellar 
white matter; bs, brainstem; Fig. 2). T2 changes after USPIO administration in –TAM and +TAM 
mice were calculated as difference T2 (24 h post)-T2(pre) injection for baseline (average of day 3 and 
10) and end stage (day 38). Computed MTR maps were re-sliced and co-registered manually to the 
high-resolution images using affine transformation. ROIs for quantitative analysis were defined on 
high-resolution images for fx, ob, cb and bs, and transposed onto MTR maps to derive values for 
baseline (average of values of day 2 and 9) and end stage (average of values of day 37 and 41). FA, 
axonal (λ║) and radial diffusivity (λ┴) were derived by performing anatomy-based ROI analysis with 
ROIs selected in cb and bs based on highresolution images. DTI parameters were derived for baseline 
time point (average values of day 3, 8 and 11) and end stage (average value of day 35 and 39). All data 
in text are given as mean ± SEM or plotted as box plot (main quartiles, sample minimum and 
maximum). Data were statistically analyzed using ANOVA and Fisher’s PLSD posthoc 
test for single comparisons. 
 
2.8 Histological analysis 
Mice were directly post-scan transcardially perfused with heparin (250 mg/l PBS, Sigma-Aldrich, 
Steinheim, Germany) in phosphate buffered saline (PBS) followed by fixation with 4 % 
paraformaldehyde (Sigma-Aldrich, Steinheim, Germany). Brains were dissected, cut into halves, post-
fixed and embedded in paraffin (Medite, Nunningen, Switzerland). Brains were sectioned into 5 μm 
coronal or sagittal sections and taken up on polysine glass slides (Menzel, Braunschweig, Germany). 
Luxol-Fast-Blue (LFB) and Luxol-Nissl (L-N) stainings were executed according to standard 
procedures. In short, sections were deparaffinized, rehydrated to 95 % alcohol, heated in 0.1 % LFB 
(Sigma-Aldrich, Steinheim, Germany) in a microwave, differentiated with 0.05 % lithium carbonate 
(Sigma-Aldrich, Steinheim, Germany) and alcohol and for L-N counterstained with cresyl violet 
acetate (Sigma-Aldrich, Steinheim, Germany).  
Prussian blue staining for iron was executed according to standard procedures. In short, sections were 
deparaffinized, rehydrated, stained for iron with potassium ferrocyanide trihydrate in hydrochloric acid 
solution and counterstained with nuclear fast red (all Sigma-Aldrich, Steinheim, Germany).  
For immunohistochemistry, sections were deparaffinized, rehydrated and exposed to heat-mediated 
antigen retrieval using a tissue microwave oven (Medite, Nunningen, Switzerland). Endogenous 
peroxidase was blocked with 3 % H2O2/methanol (Sigma-Aldrich, Steinheim, Germany), followed by 
blocking and permeabilisation with blocking buffer (10 % fetal calf serum (Brunschwig, Basel, 
Switzerland), 1 % bovine serum albumine and 0.1 % Triton X-100 (both Sigma-Aldrich, Steinheim, 
Germany) in PBS) and primary antibody (mouse-anti-CNPase (1:100; Sigma-Aldrich, Steinheim, 
Germany)) was incubated over night at 4°C in blocking buffer. Sections were washed, incubated with 
corresponding biotinylated secondary antibodies (1:500; JacksonImmunoResearch, Suffolk, United 
Kingdom) followed by incubation with Vectastain® ABC reagent mix (Reactolab, Servion, 
Switzerland) and developed with DAB metal enhancer solution (Thermo Scientific, Waltham, United 
States). Sections were documented using a Zeiss AxioImager Microscope and an AxioCam MRc5 
(Zeiss, Goettingen, Germany). Image Processing was performed using Zeiss Axiocam (Zeiss, 
Goettingen, Germany) and Photoshop (Adobe Systems Incorporated, California, United States). 
For semi- and ultrathin resin sectioning, tissues were postfixed and contrasted with 2 % osmium 
tetroxide (EMS, Hatfield, USA), dehydrated with acetone, embedded in corrected Spurr’s resin (EMS, 
Hatfield, USA) (Ellis, 2006), sectioned into 0.5 μm or 80 nm sections using a fine microtome (Ultracut 
E, Leica, Wetzlar, Germany) and taken up on standard glass slides (Menzel, Braunschweig, Germany) 
or copper EM grids (EMS, Hatfield, USA). Semithin sections for light microscopy were contrasted 
with 1 % tolluidine blue (Sigma-Aldrich, Steinheim, Germany) and ultrathin sections for electron 
microscopy with 3 % uranyl acetate and 1 % lead citrate. 
 
 
 
 
 
3. Results 
To test for effects of temporally and spatially controlled oligodendrocyte cell death we quantitatively 
assessed in individual animals intrinsic T2 values, T2 changes caused by infiltration of USPIO labeled 
monocytes, MTR and anisotropic water diffusion in diseased animals (+TAM) at baseline before the 
occurrence of clinical signs (<day 15 after first injection of tamoxifen), referring to score 0 based on 
clinical scoring, and at end stage pathology (>day 35), referring to score 2-3. Control littermates (-
TAM) underwent imaging at the same time points after injection of vehicle. 
 
3.1 Increased T2 - values in cerebellum and brainstem of diseased +TAM mice 
T2 maps of +TAM mice at end stage revealed distinct areas of pronounced hyperintensities in 
brainstem and cerebellum, regions known to be strongly affected by intrinsically triggered 
oligodendrocyte cell death (Pohl et al., 2011). Parasagittal T2 maps 0.4 mm lateral relative to Bregma 
of representative animals from -TAM or +TAM at day 2 and 41, were compared to corresponding 
Luxol-Nissl (L-N) stained histological sections of day 41. For +TAM mice a pronounced reduction in 
myelin in brainstem and cerebellum was found (Fig. 1). Hyperintense areas visible on T2 maps 
matched regions of cerebellar white matter and brain stem damage on histological sections stained 
with L-N, which appeared as less stained, vacuolized, widespread structures (visible on L-N sections). 
Quantitative analysis of T2 values derived from ROIs revealed identical values for both the +TAM 
and –TAM group at baseline (Fig. 2). At end stage of the disease process animals from +TAM group 
show significantly increased T2 values compared to -TAM in brainstem (T2 = 8.8 ± 1.5 ms, p < 
0.001; Fisher’s PLSD posthoc test) and cerebellum ROI (T2 = 9.97 ± 1.8 ms, p < 0.001) or when 
compared to both –TAM animals or +TAM mice before disease onset (for brainstem T2 = 9.84 ± 1.3 
ms p < 0.001, for cerebellum T2 = 13.5 ± 1.5 ms, p < 0.001). No other age and trait related 
differences were observed except in the frontal cortex, where we measured slightly decreased T2 
values in end stage +TAM animals compared to +TAM mice at baseline acquisition (T2 = -1.0 ± 0.4 
ms, p = 0.032) or to –TAM at end stage (T2= -1.2 ± 0.5 ms, p = 0.04). 
 
3.2 Absence of monocyte infiltration in affected brain structures of diseased +TAM mice 
To test for potential infiltration of blood-borne monocytes we assessed T2 values 24 h after systemic 
injection of USPIO at a concentration of 340 μmol Fe/kg. Quantitative analysis of changes in T2 
calculated as T2 = T2(24 h post) - T2(pre) injection (Table 1) revealed no significant difference 
related to age and trait for brainstem (overall ANOVA; F(3, 11) F=0.56, p = 0.65), and for the two 
control regions in the olfactory bulb (F=1.3, p = 0.35) and frontal cortex (F=1.05, p = 0.42). In the 
cerebellum we found a significant, albeit small difference between –TAM and +TAM animals at 
baseline (Fisher; p = 0.035), but not at end stage (p = 0.866). Prussian blue staining, specific for ferric 
iron, of corresponding tissue sections confirmed the absence of iron within the regions affected by 
oligodendrocyte cell death in the cerebellum (Suppl. Fig. 1). Only very few single Prussian blue 
positive cells have been detected (1-3 cells per brain section), which were mostly associated with 
vessels in -TAM and +TAM mice at end stage (day 38). In contrast, Prussian blue staining of liver 
sections of a naïve (untreated) animal 24 h after injection of USPIO (+USPIO) as a control showed 
strong accumulation of cell associated iron compared to injection of vehicle (-USPIO). 
 
3.3 Reduction of diffusional anisotropy in brainstem and cerebellum of diseased +TAM 
animals 
From DTI, values for fractional anisotropy (FA), axonal (λ║) and radial diffusivity (λ┴) were 
calculated. Figure 3 shows coronal T2-weighted MRI section at the level of -2.3 mm relative to 
Bregma with superimposed ROIs in cerebellar white matter and in the brainstem used for the analysis 
of diffusion parameters, the corresponding diffusion direction-dependent color-coded FA maps and 
histological sections for representative animals from –TAM and +TAM group at day 39 (end stage). 
The color-coded FA maps revealed pronounced abnormalities in +TAM animals at end stage, which 
spatially matched structures affected by demyelination indicated by as loss of myelin on 
corresponding histological sections stained for myelin content (LFB, CNPase) (Fig. 3, indicated by 
arrows). FA values of +TAM mice were significantly decreased in brainstem (overall ANOVA; F(3, 
11) F = 4.24, p = 0.045; Fig. 4) and cerebellum (F(3, 11) F=14.97, p = 0.001; Fig. 4), and when 
compared to -TAM animals at end stage (bs: p = 0.043; cb: p = 0.0006) or to +TAM at baseline (bs: p 
= 0.019; cb: p = 0.0005). Regarding directional diffusion coefficients, the analyses revealed a 
significant decrease in λ║ in diseased mice for brainstem (overall ANOVA, F(3, 11) F = 10.58, p = 
0.004) and cerebellum (F(3, 11) F = 22.21, p = 0.0003), and when compared to control at end stage 
(bs: p = 0.021; cb: p = 0.0015) or to +TAM at baseline (bs: p = 0.0097; cb: p = 0.00006). For both 
regions analyzed, no significant difference between +TAM and –TAM mice was found for radial 
diffusivity, although in the brainstem a trend of an increased λ┴ in +TAM mice at end stage was 
observed when compared to the baseline stage (Fig. 4, p = 0.056). 
 
3.4 Decreased MTR values in brainstem of diseased +TAM mice. 
Qualitative analysis of color-coded MTR maps (Fig. 5) at the level of -2.3 mm relative to the Bregma 
of representative animals from –TAM and +TAM at baseline acquisition (day 3) and end stage (day 
40) indicated a decrease in MTR values in affected areas (brainstem) for end stage +TAM mice. An 
average MTR value of brain tissue of the order of 50-55 % was found, which was slightly decreased in 
the brainstem ROI of +TAM when compared to -TAM mice at day 40. Variance analysis of MTR 
values (Table 2) revealed significant group differences for the brainstem ROI (F(3, 11) F = 3.55, p = 
0.05) between baseline and end stage +TAM mice (p=0.027) and between -TAM and +TAM at end 
stage (p = 0.038). No significant differences were observed in MTR values in cerebellar white matter 
(F(3,11) F = 1.49, p = 0.289). Similarly no difference in MTR between –TAM and +TAM animals 
was found in control ROI in the olfactory bulb or in the frontal cortex (derived from MTR sections at 
the level of +8 mm or +5 mm relative to the Bregma, respectively (ROIs and MTR maps not shown)). 
 
 
 
 
4. Discussion 
Experimentally, demyelination as occurring in MS and its histopathological and functional 
consequences are widely studied as part of the pathological cascade triggered by a primary 
inflammatory process in rat and mouse EAE. Application of T2 weighted MRI in such models 
typically revealed hyperintense lesions on T2-weighted images corresponding to regions of edema 
formation. Sites of BBB breakdown detected by Gd-DTPA enhanced MRI were in general found to 
correlate with areas of macrophage recruitment (Nessler et al., 2007; Serres et al., 2009). Detection of 
areas displaying neuronal damage such as myelin loss is commonly compromised by this dominating 
MRI signature attributed to inflammatory processes. 
In the novel mouse model investigated in this study, cell death of myelinating oligodendrocytes is 
intrinsically triggered and can be spatially and temporally controlled (Pohl et al., 2011), which allows 
studying neurodegenerative processes potentially involved in MS independent of inflammatory 
processes. This model results in an ablation of approximately 80 % of cells throughout the 
oligodendroglial lineage within a few days and produces a consistent disease course. The model is 
essentially devoid of a peripheral immunological component and myelin damage occurs 
predominantly in spatially confined areas of cerebellar white matter and brainstem. Interestingly, T2 
maps of severely affected mice displayed pronounced T2 increases within white matter tracts, as 
confirmed by histopathological analysis: for cerebellar white matter the regions of increased T2 values 
matched areas of demyelination visualized as vacuolated structures on L-N stained histological 
sections. The occurrence of discrete hyper-intense lesions on T2 -weighted images is considered an 
MRI hallmark of MS (Fazekas et al., 1999). Such T2 hyper-intensities are mainly reflecting an 
inflammatory response with other pathological processes such as demyelination, axonal loss and 
gliosis (Bruck et al., 1997; van Walderveen et al., 1998; van Waesberghe et al., 1999) contributing to 
the signal changes. 
In the model described, we did not observe any hypo-intense areas in cerebellum or brainstem. In MS 
patients, hypo-intense signals on T2-weighted images have been described at the border of early active 
lesions in patients (Landtblom et al., 1996; Bruck et al., 1997) and MS-like lesions in EAE models 
(Broom et al., 2005) and found to correlate with actively phagocyting macrophages and/or the density 
of reactive astrocytes. Reduced T2 values have been associated with partial necrosis or high cellularity 
as observed in proliferative tissue (Carrier et al., 1994; Koeller et al., 1997). In a T-cell-clone-
mediated mouse model of MS, Nessler et al. (Nessler et al., 2007) described lesion types characterized 
by a hypo-intense lesion core, for which the signal intensity in T2 weighted images showed a stronger 
correlation with the density of activated microglia cells than with reactive astrocytes. Taken together, 
there is strong evidence that hypo-intense areas on T2 -weighted images at the core or rim of early MS 
lesion reflect pronounced hypercellularity caused by infiltrating macrophages and/or activated 
microglia cells. The absence of T2 hypo-intensities in cerebellum or brainstem in this model of 
oligodendrogliopathy may therefore be attributed to its negligible inflammatory component. 
Consistent with this interpretation, USPIO-enhanced MRI, a method for monitoring the infiltration of 
blood-borne macrophages (Dousset et al., 1999a; Rausch et al., 2003; Floris et al., 2004; Berger et al., 
2006; Brochert et al., 2006; Ladewig et al., 2009) did not reveal areas of signal decreases in +TAM 
mice at any time point, reflecting very weak recruitment of blood-borne immune cells in this 
intrinsically triggered model of glial cell ablation. 
The decreased FA values observed in end stage +TAM mice as compared to –TAM animals are 
indicative of white matter disease in cerebellum and brainstem, the areas strongest affected by the 
intrinsic ablation of oligodendrocytes. Although being exquisitely sensitive to the pathological process 
affecting white matter, anisotropy is not specific to either axonal damage or demyelination. Analysis 
of directional diffusion coefficients is needed for discrimination of axonal damage associated with a 
decrease in the water diffusion parallel to the white matter fibers (λ║), and/or demyelination suggested 
to be reflected by an increase in the radial diffusion coefficient (λ┴). In the present mouse model we 
observed a pronounced decrease in axial diffusivity at end stage in both brainstem and cerebellum 
white matter structures. It has been shown that axial diffusivity is highly correlated with axonal 
damage in EAE mice (DeBoy et al., 2007; Budde et al., 2008) and mouse models of other white matter 
injuries (Sun et al., 2006; Kim et al., 2007; Mac Donald et al., 2007) resulting from the loss of 
coherent organization of the axon. Decreased axial diffusivity has been associated with axonal 
swelling (Song et al. 2005), Wallerian degeneration (Song et al. 2003), diffuse axonal injury 
(Arfanakis et al. 2002) or axonal integrity/neurofilament dysfunction (positive SMI-32 staining) 
(Budde et al., 2009; Sun et al. 2006). We attribute the strongly reduced λ║ values to axonal damage, 
which has been demonstrated by marker analysis for axonal impairment and disorganization, as well 
as morphological findings typical for axonal defects (Pohl et al., 2011) in regions affected by 
oligodendrocyte cell death. 
In the regions strongest affected by the consequences of oligodendroglial ablation, we did not observe 
a significant difference in radial diffusivity λ┴ between +TAM and –TAM mice at end stage 
pathology, which at a first glance seems contradictory to expectations for a model of specific and 
intrinsically triggered oligodendrocyte cell death. There are, however, several factors which may 
account for the absence of an increased radial diffusivity. Technical aspects include partial volume 
effects that might reduce the sensitivity of DTI in detecting effects due to demyelination. In voxels not 
entirely confined to white matter such as the region selected for brainstem, contributions of 
compartments characterized by different FA values within a given region-of-interest will reduce the 
sensitivity for detecting changes as the directional diffusivities. Nevertheless, the mean anisotropy 
values of 0.41 and 0.58 as measured in brainstem and cerebellum of -TAM mice, respectively, are 
indicative of a predominant contribution of white matter fibers possessing a uniform orientation. 
Substantial amount of remaining myelin debris and semi-intact myelin sheaths might alleviate the 
effects on diffusion perpendicular to the axon rendering them too small to significantly alter λ┴. 
Additionally, microglia and astrocytic protrusions filling the space previously occupied by myelin 
might provide diffusion barriers counteracting the possible effect by the loss of myelin membranes. 
Finally, axonal shrinkage as well as remyelination might counteract increases in lateral diffusion. Both 
in cerebellum and brainstem the radial diffusivity in +TAM at end stage tended to be higher compared 
to -TAM mice, albeit the difference did not reach the significance level. Assessing directional 
diffusivity in demyelinated lesions, which lack an inflammatory component, is an attractive tool to 
disentangle the paradox situation existing when interpreting MRI findings inherently present in EAE 
models. Although the presence of altered radial diffusivity has been shown in several demyelinating 
models (Song et al., 2005), radial diffusivity may not be as specific in the presence of other 
pathological changes. For instance, it has not been well defined whether radial diffusivity is specific to 
demyelination in the presence of significant inflammation. To what extend the absence of an 
inflammatory component in model described can be accounted for the small changes in radial 
diffusivity has to be further explored. 
Despite the absence of a clear-cut effect on radial diffusivity the significant decreases in MTR 
observed in the brainstem of diseased mice at late stage in the pathology is assumed to reflect the loss 
of myelin and its integrity, the predominant macromolecular structure rich in protons in white matter. 
MTR has been suggested to represent predominantly a measure of myelin integrity (Schmierer et al., 
2004). The relatively weak and heterogeneous changes in MTR observed in cerebellar structures in our 
model might be in part explained by the myelin debris residing in these structures at end stage (Pohl et 
al., 2011). Nevertheless, there is substantial damage or loss of myelin in brainstem areas sufficient to 
translate into a clear reduction in MTR. Interestingly in this context are recent findings in two different 
EAE models that early MTR decreases preceded the onset of demyelination (Serres et al., 2009). The 
studies confirm previous reports stating that MTR changes more closely reflect inflammatory events, 
i.e. dilution of macromolecules as a consequence of edema formation, than myelin loss (Gareau et al., 
2000). It has therefore been suggested that MTR changes in MS may reflect events leading to 
demyelination rather than demyelination per se. 
 
 
 
 
5. Conclusion 
We evaluated the sensitivity of various MRI methods to detect histopathological changes in mice after 
loss of myelinating glia. This novel mouse model based on spatially and temporally controlled 
oligodendrocyte cell ablation allowed studying the MRI signature associated to neurodegenerative 
processes related to MS in the absence of the autoimmune components that appear to be foremost in 
EAE models. Pronounced T2 hyperintensities matched the regional distribution of cell ablation in 
cerebellar and brainstem white matter as revealed by histology with affected regions being devoid of 
significant macrophage infiltration. Elevated T2 values that are commonly associated to the 
inflammatory response have been attributed to structural remodeling of white matter structures 
involving pronounced vacuolation. The significant decrease in diffusion anisotropy derived from DTI 
measures in these structures is mainly caused by a pronounced decrease in diffusivity parallel to the 
fiber indicative of axonal damage. Triggering of oligodendrocyte ablation did not translate into a 
significant increase in radial diffusivity; similarly, only minor decreases in MTR have been observed. 
It remains unclear to what extend these latter findings are due to myelin debris remaining in the tissue. 
Alternatively, it could indicate that in EAE models both radial diffusivity and MTR are significantly 
influenced by the strong initial and persistent inflammatory component. Models, such as the 
oligodendrocyte ablation model described, lacking the strong inflammatory component dominating the 
MRI signatures, should be of value in identifying potential biomarkers of MS that are characteristic for 
neurodegenerative aspects of the disease. 
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Figure Legends 
Figure 1. (A) Parasagittal, quantitative T2 maps and corresponding histological sections for 
representative animals at baseline (day 2) and end stage (day 41) after TAM-induced ablation of 
oligodendrocytes (+TAM) and controls (-TAM). Histological sections were Luxol-Nissl (L-N) stained 
for myelin content. (B) Magnifications from histological sections of end stage diseased animal are 
displayed for cerebellar regions. (C) ROIs in olfactory bulb (ob), frontal cortex (fx), brain stem (bs) 
and cerebellar white matter (cb) used for quantitative analysis of T2 relaxation times (Fig. 2) are 
shown on a parasagittal MRI section 0.4 mm lateral relative to the mid-sagittal plane. 
 
Figure 2. Box plots of T2 values for –TAM and +TAM at baseline (day 2 and day 9) and end stage 
(day 37 and day 41) derived from ROIs (Fig. 1) in brainstem (bs), cerebellar core (cb), olfactory bulb 
(ob) and frontal cortex (fx). Data are given as median, sample minimum, sample maximum, 1st and 
3rd quartiles. * = p < 0.05; **= p < 0.01. 
 
Figure 3. (A) Diffusion direction-dependent color-coded FA maps and histological sections for 
representative animals from –TAM and +TAM group at day 39 (end stage). For the color-coded maps, 
red, blue, and green colors indicate structures aligning along left–right, anterior–posterior, and 
superior–inferior orientations, respectively. Corresponding histological sections were stained for 
myelin content using luxol fast blue (LFB) and antibodies for CNPase. (B) Toluidine blue contrasted 
resin section (left) and transmission electron micrograph (right) of cerebellar white matter. Indicated 
are typical morphological findings: myelin vacuolation (black arrowhead), disrupted myelin rings 
associated with axons (empty arrowhead), and axons showing signs of impairment and shrinkage 
(asterisk). (C) ROIs in cerebellar white matter (cb) and in the brainstem (bs) used for DTI parameter 
analysis (Fig. 4) are shown on the coronal T2-weighted MRI section at the level of -2.3 mm relative to 
Bregma. 
 
Figure 4. Box plots of quantitative analysis of DTI parameters (FA: fractional anisotropy; λ║: axonal 
diffusivity; λ┴: radial diffusivity (perpendicular to main fiber orientation) for the ROIs in brainstem 
(A) and cerebellum white matter (B), respectively. Data are given as median, sample minimum, 
sample maximum and lower and upper quartiles. * = p < 0.05; **= p < 0.01 tested by ANOVA, 
Fisher’s PLSD posthoc test. 
 
Figure 5. (A) MTR maps (color-coded for percentage and superimposed on T2-weighted images) from 
representative animals for –TAM and +TAM group at day 2 (baseline) and day 41 (end stage). (B) 
ROIs in cerebellar white matter (cb) and brainstem (bs) used to quantify MT ratios (Table 1) are 
shown on the right panel superimposed on coronal T2-weighted MRI section at the level of -2.3 mm 
relative to Bregma. 
 Supplementary Figure 1. (A) Representative histological sagittal section at day 38 (corresponding to 
MRI T2 maps, Fig. 1) stained for iron (Prussian blue) and counterstained with nuclear fast red for –
TAM and +TAM 24 h post USPIO injections. Magnified sections from cerebellar white matter (cb) 
show absence of pronounced iron staining in both –TAM and +TAM. (B) Prussian blue staining of 
liver sections (liver) of a naïve (untreated) animal 24 h after injection of USPIO (+USPIO) shows 
positive control for iron staining and exposure undetectable in vehicle-injected animals (-USPIO). 
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